Home / Crime and Justice / CVS Pharmacy Fined $617K for Insulin Overcharging
CVS Pharmacy Fined $617K for Insulin Overcharging
6 Jul
Summary
- CVS Pharmacy faces a $617,160 settlement for false claims.
- Allegations involve premature insulin pen refills and over-dispensing.
- CVS admitted to improper billing practices for government healthcare programs.
Hawaiʻi will receive over $617,000 from a national CVS Pharmacy settlement concerning civil allegations of false claims for insulin pen refills.
The agreement resolves claims involving CVS's billing and dispensing practices from 2010 through 2020. Authorities alleged that CVS requested reimbursement for premature refills and dispensed excess insulin pens to patients enrolled in government healthcare programs.
As part of the settlement, CVS accepted responsibility for its conduct, acknowledging that government programs paid for ineligible insulin pen refills. The investigation stemmed from five whistleblower cases alleging violations of false claims laws.
This resolution includes the United States, the District of Columbia, and 35 states. Hawaiʻi's Attorney General highlighted the collaboration with state and federal partners in achieving this recovery.
